| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
3 companies
David J Mauro last filed a Form 4 in November 2024, as Chief Medical Officer at RXRX. The filings on record cover 3 companies. From February 2015 to November 2024, the filings on record show 0 open-market purchases and 11 sales. David J Mauro's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, David J Mauro's trades have earned a strong insider score of 90/100 across 10 rated trades. Over a 12-month horizon, all 10 of those trades were profitable, with an average 12-month return of +82.4%.
At the last filing, the largest reported position was 166,271 shares of ADXS. The ADXS filings lean toward selling, a net 24,586 shares.
Shares as reported in the last Form 4 for each company; the most recent is from November 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2015 | ADXS Ayala Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 24,586 | $10.08 | $247,826.88 | -12.9% |